Heart alert overload: Million-Patient study questions safety of common drugs
NCT ID NCT07374263
First seen Feb 02, 2026 · Last updated Jun 17, 2026 · Updated 28 times
Summary
This study looks at whether certain common medications, known as QT-prolonging drugs, actually cause serious heart problems in hospitalized adults. Researchers will analyze data from over 990,000 patients to compare those who had heart events with those who did not. The goal is to find out which patients are truly at risk and to reduce unnecessary medication alerts that can disrupt care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
GEMINI
RECRUITINGToronto, Ontario, M5B 1T8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St. Joseph's Healthcare Hamilton
RECRUITINGHamilton, Ontario, L8N 1Y3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.